Evidence map›Paper›PMID 25610764›Full record

ArticleNeuroImage. Clinical2015

The relationship between regional microstructural abnormalities of the corpus callosum and physical and cognitive disability in relapsing-remitting multiple sclerosis.

Maria Eugenia Caligiuri, Stefania Barone, Andrea Cherubini, Antonio Augimeri, Carmelina Chiriaco, Maria Trotta, Alfredo Granata, Enrica Filippelli, Paolo Perrotta, Paola Valentino and 1 more

Open access · goldAbstract read
In one paragraph

Article in NeuroImage. Clinical, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The association between retinal nerve fibre layer thickness and corpus callosum index in different clinical subtypes of multiple sclerosis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2017
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Maria Eugenia CaligiuriNeuroimaging Unit, Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Viale Europa, Germaneto, Catanzaro 88100, Italy.
Stefania BaroneInstitute of Neurology, University "Magna Graecia", Germaneto, Catanzaro 88100, Italy.
Andrea CherubiniNeuroimaging Unit, Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Viale Europa, Germaneto, Catanzaro 88100, Italy.
Antonio AugimeriNeuroimaging Unit, Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Viale Europa, Germaneto, Catanzaro 88100, Italy.
Carmelina ChiriacoNeuroimaging Unit, Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Viale Europa, Germaneto, Catanzaro 88100, Italy.
Maria TrottaInstitute of Neurology, University "Magna Graecia", Germaneto, Catanzaro 88100, Italy.
Alfredo GranataInstitute of Neurology, University "Magna Graecia", Germaneto, Catanzaro 88100, Italy.
Enrica FilippelliInstitute of Neurology, University "Magna Graecia", Germaneto, Catanzaro 88100, Italy.
Paolo PerrottaNeuroimaging Unit, Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Viale Europa, Germaneto, Catanzaro 88100, Italy.
Paola ValentinoInstitute of Neurology, University "Magna Graecia", Germaneto, Catanzaro 88100, Italy.
Aldo QuattroneNeuroimaging Unit, Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Viale Europa, Germaneto, Catanzaro 88100, Italy ; Institute of Neurology, University "Magna Graecia", Germaneto, Catanzaro 88100, Italy.
Magna Graecia University · ITNational Research Council · ITInstitute of Molecular Bioimaging and Physiology · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Significant corpus callosum (CC) involvement has been found in relapsing-remitting multiple sclerosis (RRMS), even if conventional magnetic resonance imaging measures have shown poor correlation with clinical disability measures. In this work, we tested the potential of multimodal imaging of the entire CC to explain physical and cognitive disability in 47 patients with RRMS. Values of thickness, fractional anisotropy (FA) and mean diffusivity (MD) were extracted from 50 regions of interest (ROIs) sampled along the bundle. The relationships between clinical, neuropsychological and imaging variables were assessed by using Spearman's correlation. Multiple linear regression analysis was employed in order to identify the relative importance of imaging metrics in modeling different clinical variables. Regional fiber composition of the CC differentially explained the response variables (Expanded Disability Status Scale [EDSS], cognitive impairment). Increases in EDSS were explained by reductions in CC thickness and MD. Cognitive impairment was mainly explained by FA reductions in the genu and splenium. Regional CC imaging properties differentially explained disability within RRMS patients revealing strong, distinct patterns of correlation with clinical and cognitive status of patients affected by this specific clinical phenotype.

Indexed as

AdultAnisotropyCognition DisordersCorpus CallosumDiffusion Tensor ImagingFemaleHumansImage Processing, Computer-AssistedMaleMiddle AgedMultiple Sclerosis, Relapsing-RemittingNeuropsychological TestsYoung AdultCognitive impairmentCorpus callosumDisabilityMultimodal MRIMultiple sclerosis

Identifiers

PMID25610764
PMCPMC4299954
OpenAlexW2054676690

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.